<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H7A32EA6C6D0C4F6EB13C492F61245E97" public-private="public">
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>110 HR 4530 IH: To extend temporarily the duty on
</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2007-12-13</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
	<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>110th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>H. R. 4530</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20071213">December 13, 2007</action-date>
			<action-desc><sponsor name-id="B001244">Mr. Bonner</sponsor> introduced
			 the following bill; which was referred to the
			 <committee-name committee-id="HWM00">Committee on Ways and
			 Means</committee-name></action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To extend temporarily the duty on
		  5-methyl-5-(4-phenoxyphenyl)-3-(phenylamino)-2,4-oxazolidinedione (a.k.a.
		  famoxadone) and 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide and
		  its related application adjuvants, CAS Numbers 131807–57–3 and
		  57966–95–7.</official-title>
	</form>
	<legis-body id="HBA9E5DC0E8D546D1B69E5B078DA7CE07" style="OLC">
		<section display-inline="no-display-inline" id="H6B50DDE44A0F407EA463D7F722EE94D0" section-type="section-one"><enum>1.</enum><header>Temporary extension of
			 duty</header>
			<subsection id="H91F854B271034C43ADC717FF00DDCF98"><enum>(a)</enum><header>In
			 general</header><text display-inline="yes-display-inline">Heading 9902.12.45
			 pertaining to
			 5-methyl-5-(4-phenoxyphenyl)-3-(phenylamino)-2,4-oxazolidinedione] (a.k.a.
			 famoxadone) and 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide and
			 its related application adjuvants, CAS Numbers 131807–57–3 and 57966–95–7
			 (provided for in subheading 3808.20.1500) is amended by striking the date in
			 the effective date column and inserting <quote>12/31/11</quote> in lieu
			 thereof.</text>
			</subsection><subsection id="H6A6928358FC74AF1BCA6C3A1F85CAF00"><enum>(b)</enum><header>Effective
			 date</header><text>The amendment made by this section applies with respect to
			 goods entered, or withdrawn from warehouse for consumption, on or after the
			 15th day after the date of enactment of this Act.</text>
			</subsection></section></legis-body>
</bill>


